Lundbeck
HLUN-B.CO
#2442
Rank
C$8.44 B
Marketcap
$8.84
Share price
0.62%
Change (1 day)
32.86%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total assets

Total assets on the balance sheet as of June 2024 : C$7.86 Billion

According to Lundbeck 's latest financial reports the company's total assets are C$7.86 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Lundbeck - Total assets on balance sheet (from 2009 to 2024)

Total assets by year

Year Total assets Change
2023-12-31C$7.34 B0.4%
2022-12-31C$7.31 B8.85%
2021-12-31C$6.72 B-11.46%
2020-12-31C$7.59 B1.69%
2019-12-31C$7.46 B55.49%
2018-12-31C$4.80 B19.94%
2017-12-31C$4.00 B4.13%
2016-12-31C$3.84 B-11.3%
2015-12-31C$4.33 B-10.79%
2014-12-31C$4.85 B4.26%
2013-12-31C$4.66 B22.59%
2012-12-31C$3.80 B4.49%
2011-12-31C$3.63 B13.29%
2010-12-31C$3.21 B-7.48%
2009-12-31C$3.47 B21.38%
2008-12-31C$2.86 B18.85%
2007-12-31C$2.40 B0.22%
2006-12-31C$2.40 B12.02%
2005-12-31C$2.14 B-14.82%
2004-12-31C$2.51 B